The antipsychotic chlorpromazine suppresses YAP signaling, stemness properties, and drug resistance in breast cancer cells (vol 302, pg 28, 2019)

被引:0
|
作者
Yang, Chang-En [1 ,2 ]
Lee, Wen-Ying [3 ]
Cheng, Hung-Wei [1 ,2 ]
Chung, Chu-Hung [1 ,2 ]
Mi, Fu-Lowng [1 ,2 ]
Lin, Cheng-Wei [1 ,2 ,4 ]
机构
[1] Taipei Med Univ, Sch Med, Dept Biochem & Mol Cell Biol, Coll Med, Taipei, Taiwan
[2] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan
[3] Chi Mei Med Ctr, Dept Cytopathol, Tainan, Taiwan
[4] Taipei Med Univ, Ctr Cell Therapy & Regenerat Med, Taipei, Taiwan
关键词
D O I
10.1016/j.cbi.2019.108812
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Drug-drug interactions in breast cancer patients treated with CDK4/6 inhibitors (vol 74, pg 21, 2019)
    Fogli, Stefano
    Del Re, Marzia
    Curigliano, Giuseppe
    van Schaik, Ron H.
    Lancellotti, Patrizio
    Danesi, Romano
    CANCER TREATMENT REVIEWS, 2019, 81
  • [32] Penfluridol, an antipsychotic drug suppresses breast cancer metastasis to brain by inhibiting HER2/Akt/MMP signaling axis in a novel in vivo metastasis model
    Ranjan, Alok
    Gupta, Parul
    Srivastava, Sanjay K.
    CANCER RESEARCH, 2014, 74 (19)
  • [33] Activation of MAPK Signaling by CXCR7 Leads to Enzalutamide Resistance in Prostate Cancer (vol 79, pg 2580, 2019)
    Li, Shangze
    Fong, Ka-wing
    Gritsina, Galina
    Zhang, Ali
    Zhao, Jonathan C.
    Kim, Jung
    Sharp, Adam
    Yuan, Wei
    Aversa, Caterina
    Yang, Ximing J.
    Nelson, Peter S.
    Feng, Felix Y.
    Chinnaiyan, Arul M.
    de Bono, Johann S.
    Morrissey, Colm
    Rettig, Matthew B.
    Yu, Jindan
    CANCER RESEARCH, 2020, 80 (10) : 2072 - 2072
  • [34] Discovery of YH677 as a cancer stemness inhibitor that suppresses triple-negative breast cancer growth and metastasis by regulating the TGFβ signaling pathway (vol 560, 216142, 2023)
    Zhang, Yuzhu
    Chen, Jing
    Mi, Dazhao
    Ling, Jun
    Li, Huachao
    He, Peng
    Liu, Ning
    Chen, Qianjun
    Chen, Yihua
    Huang, Luqi
    CANCER LETTERS, 2023, 567
  • [35] AQP5 silencing suppresses p38 MAPK signaling and improves drug resistance in colon cancer cells
    Shi, Xiaoming
    Wu, Shengchun
    Yang, Yongbin
    Tang, Lei
    Wang, Yuexin
    Dong, Junjie
    Lu, Bonan
    Jiang, Guangwei
    Zhao, Wei
    TUMOR BIOLOGY, 2014, 35 (07) : 7035 - 7045
  • [36] Sinomenine hydrochloride suppresses the stemness of breast cancer stem cells by inhibiting Wnt signaling pathway through down-regulation of WNT10B
    Li, Xiaomei
    Chen, Wei
    Huang, Linxi
    Zhu, Mengmei
    Zhang, Hongxia
    Si, Yachen
    Li, Hengyu
    Luo, Qing
    Yu, Bing
    PHARMACOLOGICAL RESEARCH, 2022, 179
  • [38] AhR ligand aminoflavone suppresses α6-integrin-Src-Akt signaling to attenuate tamoxifen resistance in breast cancer cells
    Campbell, Petreena S.
    Mavingire, Nicole
    Khan, Salma
    Rowland, Leah K.
    Wooten, Jonathan V.
    Opoku-Agyeman, Anna
    Guevara, Ashley
    Soto, Ubaldo
    Cavalli, Fiorella
    Irene Loaiza-Perez, Andrea
    Nagaraj, Gayathri
    Denham, Laura J.
    Adeoye, Olayemi
    Jenkins, Brittany D.
    Davis, Melissa B.
    Schiff, Rachel
    Brantley, Eileen J.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (01) : 108 - 121
  • [39] RETRACTED: Dicer Elicits Paclitaxel Chemosensitization and Suppresses Cancer Stemness in Breast Cancer by Repressing AXL (Retracted article. See vol. 78, pg. 5719, 2018)
    Chang, Ting-Yu
    Chen, Hsin-An
    Chiu, Ching-Feng
    Chang, Yi-Wen
    Kuo, Tsang-Chih
    Tseng, Po-Chun
    Wang, Weu
    Hung, Mien-Chie
    Su, Jen-Liang
    CANCER RESEARCH, 2016, 76 (13) : 3916 - 3928
  • [40] Apigenin overcomes drug resistance by blocking the signal transducer and activator of transcription 3 signaling in breast cancer cells
    Seo, Hye-Sook
    Ku, Jin Mo
    Choi, Hyeong Sim
    Woo, Jong-Kyu
    Lee, Byung Hoon
    Kim, Doh Sun
    Song, Hyun Jong
    Jang, Bo-Hyoung
    Shin, Yong Cheol
    Ko, Seong-Gyu
    ONCOLOGY REPORTS, 2017, 38 (02) : 715 - 724